Wolfe Research analyst Gal Munda initiates coverage on Trade Desk (NASDAQ:TTD) with a Peer Perform rating.
Like Moderna, BioNTech Cuts Annual Sales Forecast By 20% As Pandemic Fades
BioNTech SE (NASDAQ: BNTX) has reported Q3 revenues of €895.3 million ($974.49 million), sharply down from €3.461 billion a year ago.
